Triazole compounds and the use thereof as dopamine-D3 -ligands

US6472392B1 · kind B1 · utility

Assignee

• Abbott Laboratories · US

Inventors

• Dorothea Starck · Ludwigshafen, DE
• Stefan Blank · Ludwigshafen, DE
• Hans-Jörg Treiber · Münstermaifeld, DE
• Liliane Unger · Ludwigshafen, DE
• Barbara Neumann-Schultz · Ladenburg, DE
• Theophile-Marie Le Bris · Bobenheim am Berg, DE
• Hans-Jurgen Teschendorf · Dudenhofen, DE
• Karsten Wicke · Ludwigshafen, DE

Key dates

• Filing date: Dec 28, 1999
• Grant date: Oct 29, 2002
• Expiry date: Dec 28, 2019

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Triazole compounds of the following formula: where Ar1, A, B and Ar2 have the meanings given in the description, possess a high affinity for the dopamine D3 receptor and can therefore be used for treating diseases which respond to dopamine D3 ligands.